Doctor profile · Federal record
Dr. Rachel Kokal, PA-C
Medical Physician Assistant (CMS: Physician Assistant) · Fairfax, VA
- NPI 1144644774
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 13 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
3025 Hamaker CT, Suite 300
Fairfax, VA 220312237
(703) 849-8036
fax (703) 204-3448 - Mailing address
-
801 York St
Manitowoc, WI 542204630
Credentials & registration
- NPI registered
- February 2014 — 12 yrs on file
- Profile last updated
- July 21, 2022
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 363AM0700X — NUCC code
- State license (1)
- Virginia #0110-004473
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1144644774. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,052
Distinct HCPCS
10
Medicare allowed
$106,997
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 714 | 143 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 412 | 294 | $81 | |
17000 |
Destruction of precancer skin growth, 1 growth | 279 | 206 | $47 | |
11102 |
Biopsy of related skin growth, first growth | 190 | 163 | $80 | |
17110 |
Destruction of skin growth, 1-14 growths | 164 | 135 | $104 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 89 | 79 | $51 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 81 | 81 | $101 | |
11103 |
Biopsy of related skin growth, each additional growth | 55 | 40 | $46 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 47 | 39 | $115 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 21 | 14 | $155 |
In context: peer comparison
Among 5 peers in Fairfax Medical Physician Assistant, average services per provider: 214. This provider delivers 9.6× the peer median.Open Payments
Industry payments received
All-time total
$1,190
Transactions
59
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 10 | $271.67 | |
| Abbvie INC. | 10 | $164.86 | |
| Leo Pharma INC. | 4 | $83.47 | |
| Ucb, INC. | 4 | $78.44 | |
| Incyte Corporation | 4 | $78.26 | |
| Pfizer INC. | 5 | $76.76 | |
| Novartis Pharmaceuticals Corporation | 5 | $74.25 | |
| Regeneron Healthcare Solutions, INC. | 4 | $65.96 | |
| Sun Pharmaceutical Industries INC. | 3 | $54.59 | |
| Lilly USA, LLC | 3 | $51.94 | |
| Dermavant Sciences, INC. | 2 | $46.51 | |
| Almirall LLC | 2 | $38.52 | |
| Genzyme Corporation | 1 | $24.09 | |
| Amgen INC. | 1 | $21.56 | |
| Verrica Pharmaceuticals INC. | 1 | $21.26 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
168
Patients
90
Total drug cost
$16,203
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 45 | 40 | $362 |
| Clobetasol Propionate | Generic | 24 | 15 | $1,880 |
| Ketoconazole | Generic | 24 | 16 | $585 |
| Mupirocin | Generic | 24 | 19 | $279 |
| Jublia (Efinaconazole) | Brand | 14 | 0 | $11,422 |
| Fluocinonide | Generic | 13 | 0 | $874 |
| Nystatin | Generic | 13 | 0 | $241 |
| Nystatin-Triamcinolone (Nystatin/Triamcinolone Acet) | Brand | 11 | 0 | $559 |
Frequently asked questions
What is Dr. Rachel Kokal's medical specialty?
Dr. Rachel Kokal practices Medical Physician Assistant in Fairfax, VA.
Where does Dr. Rachel Kokal practice?
Dr. Rachel Kokal practices at 3025 Hamaker CT, Fairfax, VA 220312237. Office phone: 7038498036.
What is Dr. Rachel Kokal's NPI?
Dr. Rachel Kokal's National Provider Identifier (NPI) is 1144644774, issued by NPPES.
Does Dr. Rachel Kokal accept Medicare assignment?
Yes. Dr. Rachel Kokal accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachel Kokal commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.